Viking Therapeutics' Convertible Note Round

Viking Therapeutics raised a round of funding on May 23, 2014. Investors include Ligand Pharmaceuticals.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking's research …

Articles about Viking Therapeutics' Convertible Note Round: